PTH and chronic kidney disease: It is acknowledged that while empirical data suggest a higher 25(OH)D range is required for PTH suppression, a definitive, consensus-driven therapeutic target remains a subject of ongoing debate and complexity across the spectrum of CKD stages and patient populations (including transplant recipients) [61].